Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
GNE.NZ Stock Summary
Top 10 Correlated ETFs
GNE.NZ
In the News
GNE.NZ Financial details
Company Rating
Buy
Market Cap
2.55B
Income
371.2M
Revenue
5.19B
Book val./share
2.3
Cash/share
0.06
Dividend
0.18
Dividend %
7.07%
Employees
1.27K
Optionable
No
Shortable
Yes
Earnings
21 Feb 2024
P/E
16.42
Forward P/E
-
PEG
2.41
P/S
1.02
P/B
1.1
P/C
39
P/FCF
12.48
Quick Ratio
0.39
Current Ratio
0.75
Debt / Equity
0.51
LT Debt / Equity
0.44
-
-
EPS (TTM)
0.35
EPS next Y
-
EPS next Q
-
EPS this Y
-9.52%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
26.65%
Revenue last 5Y
-2.34%
Revenue Q/Q
9.48%
EPS Q/Q
-24.52%
-
-
-
-
SMA20
-4.45%
SMA50
-7.09%
SMA100
0.43%
Inst Own
-
Inst Trans
-
ROA
3%
ROE
11%
ROC
0.06%
Gross Margin
62%
Oper. Margin
10%
Profit Margin
6%
Payout
96%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2.3-2.78
52W High
+17%
52W Low
+17%
RSI
30.84
Rel Volume
1.25
Avg Volume
292.47K
Volume
366.49K
Perf Week
-2.09%
Perf Month
-5.65%
Perf Quarter
-1.68%
Perf Half Y
-3.31%
-
-
-
-
Beta
0.452
-
-
Volatility
0.01%, 0.05%
Prev Close
-0.43%
Price
2.34
Change
0%
GNE.NZ Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-06-30
Metric | History | 2019-06-30 | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.65 | 2.52 | 3.09 | 2.71 | 2.25 | |
Net income per share | 0.06 | 0.04 | 0.03 | 0.21 | 0.19 | |
Operating cash flow per share | 0.23 | 0.23 | 0.25 | 0.19 | 0.33 | |
Free cash flow per share | 0.15 | 0.16 | 0.19 | 0.1 | 0.25 | |
Cash per share | 0.06 | 0.03 | 0.1 | 0.1 | 0.06 | |
Book value per share | 2.12 | 2.01 | 1.97 | 2.28 | 2.28 | |
Tangible book value per share | 1.76 | 1.67 | 1.63 | 1.96 | 1.98 | |
Share holders equity per share | 2.12 | 2.01 | 1.97 | 2.28 | 2.28 | |
Interest debt per share | 1.34 | 1.39 | 1.43 | 1.49 | 1.36 | |
Market cap | 3.43B | 3.12B | 3.54B | 2.77B | 2.89B | |
Enterprise value | 4.66B | 4.45B | 4.86B | 4.16B | 4.19B | |
P/E ratio | 57.91 | 67.75 | 105.67 | 12.47 | 14.74 | |
Price to sales ratio | 1.28 | 1.2 | 1.1 | 0.98 | 1.21 | |
POCF ratio | 14.46 | 12.94 | 13.45 | 13.95 | 8.26 | |
PFCF ratio | 22.64 | 18.63 | 18.34 | 26.34 | 11.05 | |
P/B Ratio | 1.59 | 1.51 | 1.73 | 1.16 | 1.2 | |
PTB ratio | 1.59 | 1.51 | 1.73 | 1.16 | 1.2 | |
EV to sales | 1.74 | 1.72 | 1.51 | 1.47 | 1.76 | |
Enterprise value over EBITDA | 12.92 | 13.03 | 16.19 | 7.03 | 6.92 | |
EV to operating cash flow | 19.65 | 18.48 | 18.47 | 20.95 | 12.01 | |
EV to free cash flow | 30.75 | 26.61 | 25.2 | 39.54 | 16.06 | |
Earnings yield | 0.02 | 0.01 | 0.01 | 0.08 | 0.07 | |
Free cash flow yield | 0.04 | 0.05 | 0.05 | 0.04 | 0.09 | |
Debt to equity | 0.6 | 0.66 | 0.7 | 0.63 | 0.57 | |
Debt to assets | 0.28 | 0.3 | 0.27 | 0.28 | 0.27 | |
Net debt to EBITDA | 3.41 | 3.91 | 4.41 | 2.35 | 2.16 | |
Current ratio | 0.96 | 1.46 | 0.78 | 1.05 | 0.75 | |
Interest coverage | 2.22 | 1.96 | 1.84 | 6.16 | 4.68 | |
Income quality | 4.01 | 5.24 | 8.31 | 0.89 | 1.78 | |
Dividend Yield | 0.04 | 0.04 | 0.05 | 0.06 | 0.05 | |
Payout ratio | 2.22 | 3.01 | 4.84 | 0.74 | 0.74 | |
Sales general and administrative to revenue | 0.04 | 0 | 0 | 0 | 0.06 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.08 | 0.08 | 0.07 | 0.06 | 0.06 | |
Capex to operating cash flow | -0.36 | -0.31 | -0.27 | -0.47 | -0.25 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.03 | -0.04 | |
Capex to depreciation | -0.41 | -0.34 | -0.35 | -0.42 | -0.34 | |
Stock based compensation to revenue | -0.16 | -0.16 | -0.11 | -0.21 | -0.22 | |
Graham number | 1.67 | 1.42 | 1.19 | 3.3 | 3.08 | |
ROIC | 0.03 | 0.03 | 0.02 | 0.07 | 0.07 | |
Return on tangible assets | 0.01 | 0.01 | 0.01 | 0.04 | 0.04 | |
Graham Net | -2.16 | -2.19 | -2.67 | -2.4 | -2.24 | |
Working capital | -18.1M | 138.2M | -254.1M | 36.9M | -195.5M | |
Tangible asset value | 1.79B | 1.72B | 1.7B | 2.05B | 2.09B | |
Net current asset value | -2B | -2.07B | -2.26B | -2.16B | -2.09B | |
Invested capital | 0.6 | 0.66 | 0.7 | 0.63 | 0.57 | |
Average receivables | 227.9M | 230.85M | 287.2M | 291.25M | 244.85M | |
Average payables | 223.6M | 237.55M | 312.05M | 319.4M | 242.8M | |
Average inventory | 98.15M | 112M | 95.6M | 148.05M | 172.95M | |
Days sales outstanding | 30.84 | 33.14 | 38.52 | 31.36 | 37.77 | |
Days payables outstanding | 44.55 | 36.94 | 49.84 | 36.99 | 62.04 | |
Days of inventory on hand | 23.25 | 15.5 | 11.89 | 30.23 | 37.39 | |
Receivables turnover | 11.83 | 11.01 | 9.48 | 11.64 | 9.66 | |
Payables turnover | 8.19 | 9.88 | 7.32 | 9.87 | 5.88 | |
Inventory turnover | 15.7 | 23.55 | 30.69 | 12.07 | 9.76 | |
ROE | 0.03 | 0.02 | 0.02 | 0.09 | 0.08 | |
Capex per share | -0.08 | -0.07 | -0.07 | -0.09 | -0.08 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q2
Metric | History | 2021-06-30 | 2022-06-30 | 2022-12-31 | 2023-06-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 1.39 | 1.1 | 1.16 | 1.26 | |
Net income per share | 0 | 0.13 | 0.14 | 0.05 | 0.04 | |
Operating cash flow per share | 0 | 0.1 | 0.18 | 0.15 | 0.16 | |
Free cash flow per share | 0 | 0.06 | 0.15 | 0.1 | 0.09 | |
Cash per share | 0 | 0.1 | 0.11 | 0.06 | 0.06 | |
Book value per share | 0 | 2.28 | 2.67 | 2.26 | 2.3 | |
Tangible book value per share | 0 | 1.96 | 2.36 | 1.97 | 2.3 | |
Share holders equity per share | 0 | 2.28 | 2.67 | 2.26 | 2.3 | |
Interest debt per share | 0 | 1.46 | 1.4 | 1.32 | 1.21 | |
Market cap | 0 | 2.77B | 2.71B | 2.91B | 2.7B | |
Enterprise value | 1.32B | 4.16B | 4.03B | 4.21B | 4B | |
P/E ratio | 0 | 5.05 | 4.66 | 14.42 | 17.6 | |
Price to sales ratio | 0 | 1.91 | 2.34 | 2.36 | 2 | |
POCF ratio | 0 | 26.85 | 14.34 | 18.14 | 15.82 | |
PFCF ratio | 0 | 45.35 | 17.58 | 26.86 | 28.52 | |
P/B Ratio | 0 | 1.16 | 0.97 | 1.21 | 1.09 | |
PTB ratio | 0 | 1.16 | 0.97 | 1.21 | 1.09 | |
EV to sales | 0 | 2.86 | 3.49 | 3.42 | 2.96 | |
Enterprise value over EBITDA | 0 | 18.08 | 13.5 | 18.71 | 23.85 | |
EV to operating cash flow | 0 | 40.3 | 21.32 | 26.3 | 23.45 | |
EV to free cash flow | 0 | 68.06 | 26.14 | 38.94 | 42.28 | |
Earnings yield | 0 | 0.05 | 0.05 | 0.02 | 0.01 | |
Free cash flow yield | 0 | 0.02 | 0.06 | 0.04 | 0.04 | |
Debt to equity | 0.7 | 0.63 | 0.51 | 0.57 | 0.51 | |
Debt to assets | 0.27 | 0.28 | 0.25 | 0.27 | 0.24 | |
Net debt to EBITDA | 0 | 6.03 | 4.42 | 5.8 | 7.76 | |
Current ratio | 0.78 | 1.05 | 1.04 | 0.75 | 1.15 | |
Interest coverage | 0 | 3.77 | 4.76 | 2.38 | 1.58 | |
Income quality | 0 | 0.75 | 1.3 | 3.18 | 4.45 | |
Dividend Yield | 0 | 0.03 | 0.03 | 0.02 | 0.03 | |
Payout ratio | 0 | 0.53 | 0.5 | 1.43 | 1.87 | |
Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0.07 | 0.06 | 0.06 | 0.06 | 0 | |
Capex to operating cash flow | 0 | -0.41 | -0.18 | -0.32 | -0.45 | |
Capex to revenue | 0 | -0.03 | -0.03 | -0.04 | -0.06 | |
Capex to depreciation | 0 | -0.38 | -0.29 | -0.39 | -0.71 | |
Stock based compensation to revenue | 0 | -0.22 | -0.2 | -0.24 | -0.12 | |
Graham number | 0 | 2.59 | 2.88 | 1.55 | 1.36 | |
ROIC | 0 | 0.02 | 0.03 | 0.02 | 0.01 | |
Return on tangible assets | 0 | 0.03 | 0.03 | 0.01 | 0.01 | |
Graham Net | 0 | -2.39 | -2.39 | -2.22 | -2.21 | |
Working capital | -254.1M | 36.9M | 29.1M | -195.5M | 78M | |
Tangible asset value | 1.7B | 2.05B | 2.48B | 2.09B | 2.47B | |
Net current asset value | -2.26B | -2.16B | -2.2B | -2.09B | -2.1B | |
Invested capital | 0.7 | 0.63 | 0.51 | 0.57 | 0.51 | |
Average receivables | 0 | 0 | 243.6M | 245.35M | 242.75M | |
Average payables | 0 | 0 | 254.05M | 248.55M | 253.6M | |
Average inventory | 0 | 0 | 193.25M | 163.3M | 144.55M | |
Days sales outstanding | 0 | 15.07 | 19.02 | 18.01 | 15.94 | |
Days payables outstanding | 0 | 17.96 | 26.36 | 20.59 | 20.54 | |
Days of inventory on hand | 0 | 14.67 | 18.63 | 12.41 | 11.12 | |
Receivables turnover | 0 | 5.97 | 4.73 | 5 | 5.65 | |
Payables turnover | 0 | 5.01 | 3.41 | 4.37 | 4.38 | |
Inventory turnover | 0 | 6.13 | 4.83 | 7.25 | 8.09 | |
ROE | 0 | 0.06 | 0.05 | 0.02 | 0.02 | |
Capex per share | 0 | -0.04 | -0.03 | -0.05 | -0.07 |
GNE.NZ Frequently Asked Questions
What is Genesis Energy Limited stock symbol ?
Genesis Energy Limited is a NZ stock and trading under the symbol GNE.NZ
What is Genesis Energy Limited stock quote today ?
Genesis Energy Limited stock price is $2.34 today.
Is Genesis Energy Limited stock public?
Yes, Genesis Energy Limited is a publicly traded company.